Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma.
第一作者:
Shi-He,Liu
第一单位:
Department of Surgery, University of Toledo College of Medicine and Life Sciences, Toledo, OH, 43614, USA; Department of Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, 43614, USA. Electronic address: Shi-He.Liu@Utoledo.edu.
作者:
主题词
动物(Animals);癌, 胰腺管(Carcinoma, Pancreatic Ductal);细胞系, 肿瘤(Cell Line, Tumor);地高辛(Digoxin);复方合剂(Drug Combinations);药物重新定位(Drug Repositioning);药物协同作用(Drug Synergism);高通量筛选分析(High-Throughput Screening Assays);同源盒结构域蛋白质类(Homeodomain Proteins);人类(Humans);男(雄)性(Male);二甲双胍(Metformin);小鼠(Mice);分子靶向治疗(Molecular Targeted Therapy);胰腺肿瘤(Pancreatic Neoplasms);斯伐他汀(Simvastatin);反式激活因子类(Trans-Activators)
DOI
10.1016/j.canlet.2020.08.002
PMID
32829010
发布时间
2022-01-20
- 浏览2
Cancer letters
97-107页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文